New Findings Detail How Virus Prepares to Infect Cells

Article

Researchers have learned the atomic-scale arrangement of proteins in a structure that enables a virus to invade and fuse with host cells, showing precisely how the structure morphs with changing acidity to initiate infection.

 

Findings from a team at Purdue University showed the protein structure in an acidic environment, and another team from the Pasteur Institute showed the same structure in a neutral environment. When combined, the two studies illustrate what happens to the structure as a virus enters and then prepares to fuse with a host cell, critical steps leading to infection.

 

"These findings represent a milestone," says Michael Rossmann, Purdue's Hanley Distinguished Professor of Biological Sciences, who is working with Long Li, a postdoctoral researcher in his lab, and Joyce Jose, a postdoctoral researcher in the laboratory of Richard Kuhn, a professor and head of Purdue's Department of Biological Sciences.

 

The research is aimed at learning precisely how viruses infect humans and other hosts, knowledge that may lead to better vaccines and antiviral drugs, Rossmann says.

 

Findings from the Purdue and Pasteur Institute studies are detailed in two papers appearing in the journal Nature on Dec. 2. The Purdue paper was written by Li, Jose, postdoctoral researcher Ye Xiang, Kuhn and Rossmann.

 

The researchers studied alphaviruses, a family of viruses that includes eastern equine encephalitis and chikungunya viruses, which are transmitted by mosquitoes and sometimes ticks. The work focused on two "envelope proteins" making up 80 spikelike structures protruding from the outer shell of the viruses.

 

"The spikes have all the machinery for infecting a cell," Rossmann says.

 

Researchers have known the structure of envelop protein 1, or E1, for several years. The Purdue researchers have now determined the structure of envelope protein 2 and the precise atomic-scale architecture of the combined E1-E2 complex. Scientists had previously determined general characteristics about E2, such as its location in the protein complex, but they did not know its structure until now.

 

E2, a receptor-binding protein, enables the virus to initially attach to and enter host cells where the virus encounters an acidic environment that induces changes in the structure of the protein complex. These changes expose a portion of E1 required to fuse the virus with the cell membrane, leading to the formation of a "fusion pore" through which the virus's genetic material is transferred into the host cell. Once infected, the host cell then produces new virus particles.

 

The researchers learned the shape of E2's three "domains," showing how E2 displaces one of these domains when in an acidic environment, allowing fusion with the cell membrane. The scientists used advanced imaging technologies, including cryoelectron microscopy and X-ray crystallography, to uncover critical structural details about the viruses.

 

Purdue researchers led by Rossmann and Kuhn have been studying alphaviruses for about 15 years, in work based at Purdue's Markey Center for Structural Biology.

 

The research is funded by the National Institutes of Health.

 

Purdue also is leading a team of researchers in a federally funded effort aimed ultimately at developing better vaccines and antiviral drugs against alphaviruses and flaviviruses, a family that includes West Nile and dengue.

 

Related Videos
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Related Content